Advanced therapy medicinal products (ATMPs) are a focus for biopharma. The ability to treat disease in a targeted manner, the reduced likelihood of competition, and regulatory support make such products attractive R&D targets. Mathematical models can make advanced therapy production faster and cheaper, according to researchers who urge industry to take a process-systems engineering approach.